By ‘red-flagging’ prescriptions that come from telehealth providers in other states, the proposed DEA rules may “inadvertently create barriers to care,” said Joseph Kvedar, MD. In this piece, he discusses recommendations from the ATA to help build pharmacists’ trust in filling remote prescriptions.
After the “Thunder”: How Organizations Can Realize Telehealth’s Long-term Potential
Rather than comparing telehealth services to office visits in terms of data collection – which is future – perhaps we should focus on integrating virtual care into the overall care picture, said Dr. Joe Kvedar in this piece. “It is time for telehealth to sit at the grownup’s table and be treated like an honest service.
Telehealth Reexamined: Is This As Good As It Gets?
How Do We Compete With In-Person Care?
If telehealth can consistency provide a convenient virtual environment, as well as a clinical workflow that identifies which patients and conditions are appropriate for telehealth services, it’s far more likely to be able to compete with in-person care, according to Joseph Kvedar, MD, Senior Advisor, at the MGH Center for Innovation.
“Speaking with Confidence”: Dr. Kvedar Examines the Evidence Base for Digital Health
The answer to the most basic question surrounding telehealth — ‘Is it as good as in-person care?’ — is anything but simple, according to Dr. Joseph Kvedar. In this piece, he examines the pros and cons of different types of clinical research and shares examples from recent literature that can help uncover some answers.